Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma

Jpn J Ophthalmol. 2010 Mar;54(2):117-23. doi: 10.1007/s10384-009-0779-z. Epub 2010 Apr 18.

Abstract

Purpose: To determine the target intraocular pressure (IOP) level in normal-tension glaucoma (NTG) for visual field (VF) stability following trabeculectomy.

Methods: Forty eyes of 40 patients who underwent trabeculectomy were enrolled in this study. Progression was determined by a decrease in the Advanced Glaucoma Intervention Study VF defect score of four or more points. The Kaplan-Meier life table method was employed to compare the postoperative VF stability with predetermined IOP levels.

Results: The mean postoperative follow-up period was 12 years. At the final visit, the IOP was reduced from 15.2 to 9.4 mmHg on average (P < 0.0001). Reductions in IOP of 20% from baseline were achieved in 70.0% of eyes. The cumulative probability of VF stability was 92.7% in patients having an IOP reduction of >20%, whereas all patients in the poorly controlled IOP group showed progression (P < 0.0001). When IOP values of 9, 10, 11, and 12 mmHg were employed as the cutoff, the best VF prognosis was attained in eyes with a postoperative IOP of 10 mmHg.

Conclusions: An IOP reduction of at least 20% from baseline or IOP <or=10 mmHg is recommended as the target postoperative IOP in progressive NTG.

MeSH terms

  • Adult
  • Aged
  • Alkylating Agents / administration & dosage
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Intraocular Pressure / physiology*
  • Kaplan-Meier Estimate
  • Low Tension Glaucoma / physiopathology*
  • Low Tension Glaucoma / surgery*
  • Male
  • Middle Aged
  • Mitomycin / administration & dosage
  • Probability
  • Retrospective Studies
  • Tonometry, Ocular
  • Trabeculectomy*
  • Vision Disorders / physiopathology*
  • Visual Fields*

Substances

  • Alkylating Agents
  • Mitomycin